CELH Stock Cash Flow Statements

Celsius Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Celsius Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2011-03-31

cash flows from operating activities:
net income	99,855,000	44,419,000	-18,876,000	6,356,000	79,783,000	77,811,000	50,116,000	83,949,000	51,509,000	41,227,000	-21,223,000	-181,897,000	9,159,000	6,679,000	-3,354,286	2,745,791	3,960,344	585,424	1,665,861	4,753,603	1,558,334	546,051		11,656,594	-849,772	-4,131,714	-3,348,658	-2,876,504	-5,207,812	-1,622,244	470,773	-1,881,300	-419,542	-459,632
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	9,119,000	2,611,000	2,386,000	2,240,000	1,419,000	1,229,000																		107,343	37,542	14,972	11,695	7,953	6,133	5,618	4,440	4,234	4,605	7,112
allowance for credit losses[1]	3,452,000	2,077,000
amortization of deferred other costs[2]	3,531,000	3,531,000	3,531,000
inventory excess and obsolescence	9,925,000	5,337,000	1,968,000	5,564,000	9,168,000	2,386,000	4,635,000	6,565,000	-5,560,000	1,672,000	5,053,000	747,000	-2,265,000	2,596,000
stock-based compensation expense	6,434,000	5,029,000	5,906,000	5,376,000	4,746,000	3,563,000	5,005,000	4,979,000					4,207,000	4,310,000	23,074,580	5,803,321	4,022,259	3,575,001	1,621,301	2,143,700	1,174,999	1,400,000	1,477,455	1,358,503			1,179,765	770,862			580,415	782,314	217,647
deferred income taxes-net	-4,430,000	269,000	-14,457,000	-1,385,000	-338,000	6,450,000	2,248,000	-3,259,000
change in fair value of contingent consideration
other operating activities	757,000	-1,014,000
changes in operating assets and liabilities:
accounts and note receivable-net[3]	-154,994,000	11,841,000
inventories	18,245,000	4,794,000																																693,881
prepaid expenses and other current assets	-16,958,000	-3,687,000	21,335,000	-16,792,000	-1,393,000	-2,076,000	4,426,000	-348,000	-7,892,000	-4,166,000	755,000	202,000	-2,256,000	3,513,000	9,274,473	-84,869	-5,560,712	-2,557,007	-9,895,035	-419,333	359,167	-501,586	1,282,420	-707,984	1,037,300	-662,608	483,992	-1,977,614	1,887,846	-1,104,655	-149,652	-876,634	185	-146,319
other long-term assets	2,442,000	-1,700,000	441,000	1,059,000
accounts payable[4]	9,110,000	11,679,000	11,089,000
accrued expenses[5]	1,660,000	-8,673,000	74,247,000
income taxes payable	-4,425,000	15,353,000	10,095,000	-4,653,000	-53,228,000	8,250,000	-9,560,000	57,000
accrued promotional allowance[6]	48,842,000	15,379,000	-22,862,000
other current liabilities	3,647,000	-1,648,000	826,000	1,210,000	790,000	2,094,000	2,066,000	1,716,000	2,015,000	1,508,000	319,000	471,000
deferred revenue[7]
other long-term liabilities	-1,358,000	148,000
net cash from operating activities	43,712,000	103,367,000	75,672,000	12,934,000	39,643,000	134,649,000	5,172,000	90,835,000	59,042,000	-13,831,000							-17,011,463	-13,318,001			-428,534	-3,817,544	2,000,452	-6,793,712	-2,641,556			-4,275,713						-649,141
capex	0	-6,944,000	0	0	-9,214,000	-4,525,000	-4,746,000	-5,877,000	-4,557,000	-2,253,000							-518,207	-697,843			-208,405	-107,372	-22,653	0	-16,935			-11,717						0
free cash flows	43,712,000	96,423,000	75,672,000	12,934,000	30,429,000	130,124,000	426,000	84,958,000	54,485,000	-16,084,000							-17,529,670	-14,015,844			-636,939	-3,924,916	1,977,799	-6,793,712	-2,658,491			-4,287,430						-649,141
cash flows from investing activities:
purchase of property, plant and equipment[8]
purchase of non-marketable equity securities			0
acquisition of alani nutrition llc, net of cash acquired
net cash from investing activities	-1,269,601,000	-6,944,000	-80,743,000	-7,244,000	-9,214,000	-4,525,000			-4,557,000	980,000		-1,021,000									1,122,606	-107,372
cash flows from financing activities:
cash dividends paid on series a convertible preferred stock[1]
repurchase of common stock related to employee tax withholdings
proceeds from term loan
payment of debt issuance costs and debt discount
payment of revolver fees
other financing activities	-2,000	321,000
net cash from financing activities	862,882,000	-10,587,000	-7,506,000	-5,902,000	-6,673,000	-5,885,000	-6,279,000	-5,990,000	-6,638,000	-6,314,000	-6,365,000	539,254,000	433,000	790,000	456,353	704,262	69,544,050	690,761	-8,448,740	23,537,616	331,347	151,265	-26,486	1,524,760	5,121,309	0	37,681	142,023	12,502	-64,660	973,733	10,024,948	4,000,000	-13,433
effect on exchange rate changes on cash and cash equivalents	955,000	1,259,000								-181,000					-301,404	-212,755	140,926	-164,536	144,169	520,973	-8,705	-222,930
net increase in cash and cash equivalents	-362,052,000	87,095,000	-13,558,000	538,000	23,712,000	123,517,000		78,968,000								-22,412,779			-8,910,077
cash and cash equivalents at beginning of the period	0	890,190,000	0	0	0	755,981,000		0							0	0	0	43,248,021	0	0	0	23,090,682
cash and cash equivalents at end of the period	-362,052,000	977,285,000	-13,558,000	538,000	23,712,000	879,498,000		78,968,000								-22,412,779	52,155,306	31,634,675	-8,910,077	32,047,283	1,016,714	19,094,101
supplemental disclosures:
cash paid for:
interest														2,000	2,067			1,605	148,422	41,976	121,400	136,018	0	28,632	41,984	44,439	49,727	38,259	23,841	50,480	38,478	48,056	0
taxes	41,513,000	669,000	102,000	20,862,000	77,850,000	320,000	23,699,000	23,016,000	9,625,000	408,000	13,744,000	-1,509,000
supplemental schedule of noncash investing and financing activities:
estimated fair value of contingent consideration in connection with the acquisition
estimated fair value of share consideration issued in connection with the acquisition
preliminary deferred payment owed to sellers in connection with the acquisition
deferred revenue[2]		-2,378,000	-2,378,000
purchase of property, plant and equipment[7]		-6,944,000
cash dividends paid on series a convertible preferred stock[2]		-6,781,000	-6,912,000
repurchase of common stock related to tax withholdings		-1,932,000	-603,000
payment of debt issuance costs		-2,195,000
impairment of intangible assets											0
loss on disposal of property, plant and equipment
foreign exchange loss			1,378,000	-277,000	264,000	369,000	988,000	52,000	137,000	69,000
accounts receivable[3]
note receivable-net
accrued distributor termination fees			0	0	0	-248,000	247,000	0	-1,063,000	-2,923,000	-111,565,000
change in right of use asset and lease liability-net
collections from note receivable							0	0
acquisition of big beverages contract manufacturing l.l.c., net of cash acquired
principal payments on finance lease obligations			-15,000	-16,000	-15,000	-15,000	-11,000	-11,000	-11,000	-11,000	-14,000	-12,000	-17,000	-20,000		-22,794	-24,443	-25,149
proceeds from exercise of stock options			24,000	2,685,000	180,000	967,000	682,000	896,000	229,000	478,000	579,000	1,844,000	450,000	810,000	478,068	727,056	1,799,107	715,910	1,830,448	1,591,679	489,317	215,347	0	24,760	121,309	0	37,681	142,023	12,502	-64,660	973,733	25,000	0
proceeds from issuance of series a preferred shares, net of issuance costs											0
allowance for expected credit losses[1]
loss on disposal of property and equipment				95,000			3,000	4,000
accounts receivable-net[3]
inventories-net				-22,467,000	7,666,000	29,386,000	-35,207,000	-52,724,000				7,458,000	24,222,000	4,531,000
change in right of use and lease obligation-net				51,000	-11,000	-23,000	-38,000	-26,000	-23,000	-15,000
purchase of property and equipment[7]
effect of exchange rate changes on cash and cash equivalents				750,000	-44,000	-722,000		0																288,584		65,949	33,685	-53,504
allowance for expected credit losses					1,822,000	2,250,000
amortization of deferred other costs					3,531,000	3,531,000	3,531,000	3,531,000	3,531,000	3,531,000	3,531,000
accounts receivable-net					-63,549,000	-18,664,000	31,713,000	-17,671,000	-25,961,000	-109,639,000	52,598,000	-51,047,000	6,500,000	-34,420,000	3,058,701	-10,039,888	-9,032,715	-9,234,501	1,562,666	-4,362,889	-1,522,134	-3,146,415
accounts payable					6,963,000	-3,013,000
accrued expenses					15,762,000	1,998,000
accrued promotional allowance					27,278,000	29,414,000	-36,770,000	37,585,000	30,747,000	32,248,000
deferred revenue					-2,379,000	-2,378,000	-2,130,000	-2,374,000	-3,594,000	-4,625,000	35,360,000
purchase of property and equipment					-9,214,000	-4,525,000	-4,746,000	-5,877,000	-4,557,000	-2,253,000	-4,787,000	-1,021,000	-1,714,000	-742,000	-755,068	-1,179,252	-518,207	-697,843	-157,080	-100,894	-208,405	-107,372	-22,653		-16,935	-15,419	-66,346	-11,717	-18,818	-18,370	-6,014	-6,332	-3,295
cash dividends paid on series a convertible preferred stock
gain on disposal of property and equipment						-8,000
other assets						-7,672,000	-26,000	-10,000	12,000	-4,000	-19,000
dividends on series a preferred shares						-6,837,000
allowance for credit losses							248,000	792,000	251,000	837,000
gain on lease cancellations															-13,248				0	0
net cash (used in) investing activities							-4,746,000																			-15,419	-66,346	-11,717	-18,818	-18,370	-6,014	-6,332	4,465
dividends paid on preferred shares							-6,950,000	-6,875,000	-6,856,000	-6,781,000	-6,930,000
net proceeds from sale of common stock																			-90,800				0
net increase in cash, cash equivalents and restricted cash										-19,346,000
cash, cash equivalents and restricted cash at beginning of the period										652,927,000
cash, cash equivalents and restricted cash at end of the period										633,581,000
cash paid during period for:
depreciation								723,000	549,000	404,000	410,000	396,000	311,000	245,000	29,924	341,340	70,227	108,198	45,083	31,829	-74,588	124,939
amortization								151,000	149,000	145,000	153,000	127,000	134,000	141,000	162,732	175,659	187,471	187,670	386,882	373,639	541,448	309,597
accounts payable and accrued expenses								27,143,000	-12,673,000	182,000	-16,554,000	41,126,000	-7,406,000	17,742,000	-1,508,553	39,115,245	15,466,686	12,112,637	7,295,142	-2,031,690	126,954	2,729,700	2,652,230	-2,070,134	344,063	7,013,057	-2,731,833	3,908,101	-2,099,162	5,030,379	-199,314	1,825,713	43,730	-132,122
share-based payment expense										5,507,000
deferred income taxes										2,873,000
inventory-net										17,338,000					-71,253,009
proceeds from note receivable										3,233,000	0	0			0	9,451	0	1,876,273	0	0
adjustments to reconcile net income to net cash (used in)/provided by operating activities:
bad debt expense											1,647,000	239,000	11,000	455,000	1,700,828
foreign exchange gain
net cash from in investing activities
payments on bonds payable
cash paid on taxes on restricted stock awards
net proceeds from collection of section 16b short swing profit
european acquisition adjustment:
goodwill																			0	0
other liabilities																			0	0
adjustments to reconcile net income to net cash from /(used in) operating activities:
share-based compensation expense
un-realized exchange gain
deferred tax-net												30,257,000	-1,489,000	2,561,000
change in right of use assets and lease obligation-net												-31,000	-17,000	-78,000
net cash provided by/(used in) operating activities												128,671,000
proceeds from issuance of common stock
effect on exchange rate changes on cash												37,000	17,000	104,000
net increase in cash and restricted cash
cash and restricted cash at beginning of the period
cash and restricted cash at end of the period
supplemental cash flow disclosures:
united states												829,000	1,303,000	3,330,000
sweden												-18,000	-47,000	1,314,000
finland												14,000	-50,000	419,000
norway
long-lived assets related to foreign operations												11,000	-97,000	1,733,000
total long-lived assets-net												840,000	1,206,000	5,063,000
adjustments to reconcile net income to net cash /provided/(used in) by operating activities:
un-realized exchange loss													517,000	85,000
proceeds from capital raise																0
net increase in cash																								-4,980,368			-1,491,802	-4,198,911				9,157,349
cash at beginning of the period													0	16,255,000										7,743,181		0	0	14,186,624		0	0	11,747,138
cash at end of the period													34,499,000	25,532,000										2,762,813		-3,181,799	-1,491,802	9,987,713		-579,160	-906,744	20,904,487
deposits and other current liabilities														765,000
net cash (used in)/provided by operating activities														9,125,000
net cash provided by/(used in) investing activities														-742,000
net increase/(decrease) in cash														9,277,000
deferred tax asset-net
gain on china transaction																			61,557	-407,593	-121,303	144,403
deferred tax liability-net															0
net cash (used)/provided by operating activities
net cash provided/(used) in investing activities																		1,178,430	-157,080
principal payments on financial lease obligations
net (decrease)/increase in cash
unrealized currency gain
inventory excess and obsolescence expense
change in right-of-use asset and lease liability-net																22,495	12,545	-4,575
net cash (used in)/provided by investing activities
non-cash investing and financing activities:
bad debt allowance																	631,572	223,034	12,492	23,503	-40	221,222
inventory excess and obsolescence allowance																	506,141	753,935	535,685	349,192	133,340	-270,710
deposits/deferred revenue and other current liabilities																	165,597	174,355	-353,304	147,710	6,570	102,743
cash paid during period for: interest
inventory																		-19,242,172	-3,260,115	7,484,034	-2,607,391	-5,475,308	-2,497,942	258,688
net decrease in cash and cash equivalents																		-11,613,346
change in right to use and lease obligation-net																			622	3,883	148,222	-2,180
cash consideration for acquisition-net of cash from acquisition
proceeds from notes payable-related-party
debt conversion and related accrued expenses
net cash provided/(used) in operating activities
cash paid to escrow for acquisition
principal payments financial lease obligations																				-37,179	-157,970	-64,082
net (decrease) in cash and cash equivalents																					1,016,714	-3,996,581
adjustments to reconcile net income/(loss) to net cash provided/used in operating activities:
net income/
loss on debt extinguishment
stock-based compensation expense for services																													0
accrued preferred dividends																									-5,805	-44,234	4,234	-51,111	-51,111	-50,556	-50,000	-51,111	-51,138
principal payments-finance leases
net increase/(decrease) in cash and cash equivalents
cash and cash equivalents at beginning of the year
cash and cash equivalents at end of the year
preferred dividends
debt conversion and related accrued expenses into common stock
non-cash items related to china settlement:
accounts receivable																							0	-2,488,198	-143,405	-6,212,457	2,449,346	-2,698,222	696,230	-2,217,930	-1,580,017	-486,209	614,539	-518,466
pre-paid expense and other current assets																							0	175,185
european acquisition detail of assets acquired & liabilities assumed:
intangible assets
lease liability obligations
bonds payable
adjustments to reconcile net income/(loss) to net cash from operating activities:
shares issued for settlement of legal claim
allowance for bad debt
inventory allowance for excess and obsolete products
gain on investment repayment from china																								-12,273,213
accounts receivable-gross
unbilled royalty revenue																								-89,587
other current assets/liabilities																								45,463
proceeds from notes payable related party-net																								1,500,000
inventories net																								-2,332,499		-617,726	437,713	-1,363,237		-1,059,135	-679,841	-366,250
proceeds from sale of equipment
conversion of convertible note to common stock, related party
conversion of accrued preferred dividend into preferred shares - related party
stock-based option compensation expense
deferred revenue and other current liabilities																										-24,370	16,924	4,059		-78,333	-263,267	179,976
net proceeds from issuance of common stock																														0	0	9,999,948
net increase increase in cash																														-579,160
income taxes
conversion of convertible note to common stock, related-party																														0
net cash from in operating activities																														-496,130	-1,874,463	-861,267
conversion of convertible note to common shares, related-party																																1,000,000
gain on equipment
adjustments to reconcile net (loss) to net cash from operating activities:
1.
4
borrowing under revolving note payable, related-party
repayment on short term notes payable, related-party
payments on short term notes payable
borrowing under short term notes payable for prepaid expense
preferred stock issued in exchange for cancellation of revolving note payable - related party
conversion of convertible note to common shares - related party
preferred stock issuance in exchange for cancellation of revolving note payable, related-party
conversion of accrued preferred dividend into preferred shares, related-party
adjustments to reconcile net income to net cash
used in operating activities:
loss on disposal of assets
adjustment to allowance for doubtful accounts																																		-17,578
adjustment to reserve for inventory obsolescence																																		-106,862
issuance of stock options																																		30,845
amortization of debt discount
loss on extinguishment of debt
purchases of property, fixtures and equipment
proceeds from sale of common stock
and exercise of stock options
repayment of loans payable
proceeds from debt to related parties
repayment of debt to related parties																																		-13,433
increase in cash																																		-662,574
cash, beginning of period																																		1,320,665
cash, end of period																																		658,091
supplemental disclosures of cash flow information:
cash paid during the year for interest																																		61,284
cash paid during the year for taxes
issuance of shares for note payable

We provide you with 20 years of cash flow statements for Celsius stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Celsius stock. Explore the full financial landscape of Celsius stock with our expertly curated income statements.

The information provided in this report about Celsius stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.